Zheng Quan Shi Bao Wang·2025-09-15 10:33Group 1 - The CRO concept sector rose by 1.44%, ranking 8th among concept sectors, with 42 stocks increasing in value, including notable gainers such as Dezheng Health, Zhaoyan New Drug, and ST Weiming, which hit the daily limit, while Boteng Co., Haofan Bio, and Kanglong Chemical saw significant increases of 9.21%, 9.10%, and 6.37% respectively [1][2] - The sector experienced a net inflow of 778 million yuan from main funds, with 35 stocks receiving net inflows, and 7 stocks attracting over 50 million yuan, led by Kanglong Chemical with a net inflow of 172 million yuan, followed by Kailaiying, WuXi AppTec, and Dezheng Health with net inflows of 159 million yuan, 148 million yuan, and 148 million yuan respectively [2][3] Group 2 - In terms of fund inflow ratios, Dezheng Health, Haoyuan Pharmaceutical, and New World had the highest net inflow ratios at 30.08%, 12.93%, and 11.07% respectively [3] - The CRO concept fund inflow rankings showed that Kanglong Chemical had a daily increase of 6.37% with a turnover rate of 6.31%, while Kailaiying and WuXi AppTec also performed well with increases of 4.11% and 1.45% respectively [4][5] - The overall performance of the CRO sector was mixed, with some stocks like ST Weiming and *ST Shuangcheng experiencing declines of 2.19% and 1.92% respectively, indicating volatility within the sector [1][6]